long-acting β2-agonists (LABAs)

February 5, 2016May 13, 2016

New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in U.S.

Asthma, COPD, News

Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food ... Read more

September 16, 2015November 9, 2015

UMEC/VI Fixed-Dose Bronchodilator is as Efficient as other Bronchodilator Therapies in COPD

COPD, News

In a new study entitled “Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis,” authors performed a comparative analysis of the efficacy of umeclidinium and vilanterol bronchodilator fixed-dose, ... Read more